Ciprokiren

This classification denotes an antihypertensive agent with the molecular formula C37H55N5O8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, K259Z4O1B3 chemically known as (.alpha.s)-n-((1s,2r,3s)-1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl)-.alpha.-((.alpha.s)-.alpha.-(((1-methyl-1-(morpholinocarbonyl)ethyl)sulfonyl)methyl)hydrocinnamamido)imidazole-4-propionamide but generally known as ciprokiren, which bears US NIH Compound Identifier 64925. European Medicines Agency schedules Ciprokiren in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07471MIG. The term CIPROKIREN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34. ). Most nations schedule ciprokiren under HS 29349990 and SITC 51579. As of Q4 2014, CIPROKIREN remains the US FDA Preferred Term for this commodity. Ciprokiren bears US NLM identifiers UMLS ID C0251321 and NCI Concept Code C79133. SMILES: CC(C)(C(=O)N1CCOCC1)S(=O)(=O)CC(CC2=CC=CC=C2)C(=O)NC(CC3=CN=CN3)C(=O)NC(CC4CCCCC4)C(C(C5CC5)O)O.